Treating osteomyelitis: antibiotics and surgery
- PMID: 21200289
- DOI: 10.1097/PRS.0b013e3182001f0f
Treating osteomyelitis: antibiotics and surgery
Abstract
Background: Osteomyelitis is an inflammatory disorder of bone caused by infection leading to necrosis and destruction. It can affect all ages and involve any bone. Osteomyelitis may become chronic and cause persistent morbidity. Despite new imaging techniques, diagnosis can be difficult and often delayed. Because infection can recur years after apparent "cure," "remission" is a more appropriate term.
Methods: The study is a nonsystematic review of literature.
Results: Osteomyelitis usually requires some antibiotic treatment, usually administered systemically but sometimes supplemented by antibiotic-containing beads or cement. Acute hematogenous osteomyelitis can be treated with antibiotics alone. Chronic osteomyelitis, often accompanied by necrotic bone, usually requires surgical therapy. Unfortunately, evidence for optimal treatment regimens or therapy durations largely based upon expert opinion, case series, and animal models. Antimicrobial therapy is now complicated by the increasing prevalence of antibiotic-resistant organisms, especially methicillin-resistant Staphylococcus aureus. Without surgical resection of infected bone, antibiotic treatment must be prolonged (≥4 to 6 weeks). Advances in surgical technique have increased the potential for bone (and often limb) salvage and infection remission.
Conclusions: Osteomyelitis is best managed by a multidisciplinary team. It requires accurate diagnosis and optimization of host defenses, appropriate anti-infective therapy, and often bone débridement and reconstructive surgery. The antibiotic regimen must target the likely (or optimally proven) causative pathogen, with few adverse effects and reasonable costs. The authors offer practical guidance to the medical and surgical aspects of treating osteomyelitis.
Comment in
-
Discussion. Treating osteomyelitis: antibiotics and surgery.Plast Reconstr Surg. 2011 Jan;127 Suppl 1:188S-189S. doi: 10.1097/PRS.0b013e3182028e99. Plast Reconstr Surg. 2011. PMID: 21200290 No abstract available.
Similar articles
-
Diagnosis and treatment of diabetic foot infections.Plast Reconstr Surg. 2006 Jun;117(7 Suppl):212S-238S. doi: 10.1097/01.prs.0000222737.09322.77. Plast Reconstr Surg. 2006. PMID: 16799390
-
Update on the diagnosis and management of osteomyelitis.Clin Podiatr Med Surg. 1996 Oct;13(4):701-24. Clin Podiatr Med Surg. 1996. PMID: 9026404 Review.
-
Treatment of diabetic foot osteomyelitis: A surgical critique.Int J Low Extrem Wounds. 2010 Mar;9(1):37-59. doi: 10.1177/1534734610361949. Int J Low Extrem Wounds. 2010. PMID: 20207622
-
Successful treatment of chronic osteomyelitis in children with debridement, antibiotic-laden cement spacer and bone graft substitute.Eur J Orthop Surg Traumatol. 2017 Feb;27(2):221-228. doi: 10.1007/s00590-016-1859-7. Epub 2016 Sep 19. Eur J Orthop Surg Traumatol. 2017. PMID: 27644427
-
Duration of post-surgical antibiotics in chronic osteomyelitis: empiric or evidence-based?Int J Infect Dis. 2010 Sep;14(9):e752-8. doi: 10.1016/j.ijid.2010.01.005. Epub 2010 May 14. Int J Infect Dis. 2010. PMID: 20471296 Review.
Cited by
-
An Andrias davidianus derived composite hydrogel with enhanced antibacterial and bone repair properties for osteomyelitis treatment.Sci Rep. 2024 Oct 19;14(1):24626. doi: 10.1038/s41598-024-75997-8. Sci Rep. 2024. PMID: 39426986 Free PMC article.
-
Orthopedic Dermatopathies: Skin Manifestations in Orthopedic Conditions.J Orthop Sports Med. 2024;6(3):171-183. doi: 10.26502/josm.511500157. Epub 2024 Aug 30. J Orthop Sports Med. 2024. PMID: 39399309 Free PMC article.
-
Analysis of risk factors for the recurrence of osteomyelitis of the limb after treatment with antibiotic-loaded calcium sulfate and autologous bone graft.Front Bioeng Biotechnol. 2024 May 14;12:1368818. doi: 10.3389/fbioe.2024.1368818. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38807650 Free PMC article.
-
Current application and future perspectives of antimicrobial degradable bone substitutes for chronic osteomyelitis.Front Bioeng Biotechnol. 2024 Mar 27;12:1375266. doi: 10.3389/fbioe.2024.1375266. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38600942 Free PMC article. Review.
-
Inflammatory Microenvironment-Responsive Hydrogels Enclosed with Quorum Sensing Inhibitor for Treating Post-Traumatic Osteomyelitis.Adv Sci (Weinh). 2024 May;11(20):e2307969. doi: 10.1002/advs.202307969. Epub 2024 Mar 14. Adv Sci (Weinh). 2024. PMID: 38482752 Free PMC article.
References
-
- Mader JT, Ortiz M, Calhoun JH. Update on the diagnosis and management of osteomyelitis. Clin Podiatr Med Surg. 1996;13:701–724.
-
- Mader JT, Shirtliff ME, Bergquist SC, Calhoun J. Antimicrobial treatment of chronic osteomyelitis. Clin Orthop Relat Res. 1999;360:47–65.
-
- Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004;364:369–379.
-
- Mackowiak PA, Jones SR, Smith JW. Diagnostic value of sinus-tract cultures in chronic osteomyelitis. JAMA. 1978;239:2772–2775.
-
- Howard CB, Einhorn M, Dagan R, Yagupski P, Porat S. Fine-needle bone biopsy to diagnose osteomyelitis. J Bone Joint Surg Br. 1994;76:311–314.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
